There are several new drugs BMS-354825 and AMN-107 are the two that are currently the best known. BMS-354825 is dasatinib which has been shown in clinical trials to be more effective than Gleevec and has much fewer side effects. It is expected to be approved by FDA in the next 4 to 6 weeks and will be available by prescription at that time. There are clinical trials ongoing currently which would be an option for CML patients who need to get on the drug before FDA approval. There is a link to all of the latest CML trials at the top of the page at http://cmlhope.com

In addition to the BMS and AMN drugs there are other drugs in the pipeline as well.

Rob


On 4/28/06, Joseph Cancemi <[EMAIL PROTECTED]> wrote:
I saw your post on the new treatment about to be approved for Gleevec resistent cml patients.
 
What is that new drug called?
 
Thanks,
 
JC






--
Powered by NewOrleansEmail.Com http://neworleansemail.com
--~--~---------~--~----~------------~-------~--~----~
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------

You received this message because you are subscribed to the Google Groups "CMLHope" group.
To post to this group, send email to CMLHope@googlegroups.com
To unsubscribe from this group, send email to [EMAIL PROTECTED]
For more options, visit this group at http://groups.google.com/group/CMLHope
-~----------~----~----~----~------~----~------~--~---

Reply via email to